1 0

    FDA FAERS Summary Adverse Events for Ayvakit (Avapritinib) – Jan 2023–Present

    FDA FAERS Summary Adverse Events for Ayvakit (Avapritinib) – Jan 2023–Present

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: I request all summary adverse events reported to the FAERS database for Ayvakit (generic name: avapritnib) from January 1, 2023 to present. Please provide the files in Excel or pdf format. 
    Tags: Pharma, FAERS, 2023

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details